Deep sea has an extreme environment which leads to biodiversity of microorganisms and their unique physical and biochemical mechanisms. Deep-sea derived microorganisms are more likely to produce novel bioactive substances with special mechanism of action for drug discovery. This article reviews secondary metabolites with biological activities such as anti-tumor, anti-bacterial, anti-viral, and anti-inflammatory isolated from deep-sea fungi and bacteria during 2018–2020. Effective methods for screening and obtaining natural active compounds from deep-sea microorganisms are also summarized, including optimizing the culture conditions, using genome mining technology, biosynthesis and so on. The comprehensive application of these methods makes broader prospects for the development and application of deep sea microbial bioactive substances.
CITATION STYLE
Wang, Y. N., Meng, L. H., & Wang, B. G. (2020, December 1). Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms. Marine Drugs. MDPI. https://doi.org/10.3390/md18120614
Mendeley helps you to discover research relevant for your work.